Comprehensive disease control in patients with Ulcerative Colitis: refinement of a multi-component endpoint using data from the filgotinib SELECTION trial

Category Primary study
JournalJournal of Crohn's and Colitis
Year 2024
This article has no abstract
Epistemonikos ID: d05c7a1b5bdd5b0d25f3d20c6073a86a9c2a8b51
First added on: Feb 19, 2025